Evidence level for effectiveness of glucagon-like peptide-1 receptor agonists respectively sodium glucose co-transporter-2 inhibitors for mitochondrial diabetes is low. (2020). Innovative Journal of Medical and Health Sciences, 10(06), 959-960. http://www.innovativejournal.in/index.php/ijmhs/article/view/2988